Cannabics Pharmaceuticals (OTCMKTS:CNBX) and Innovative Industrial Properties (NYSE:IIPR) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, risk, dividends and valuation.
Valuation and Earnings
This table compares Cannabics Pharmaceuticals and Innovative Industrial Properties' revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Cannabics Pharmaceuticals | N/A | N/A | N/A | N/A | N/A |
Innovative Industrial Properties | $44.67 million | 101.23 | $23.48 million | $3.27 | 57.80 |
Innovative Industrial Properties has higher revenue and earnings than Cannabics Pharmaceuticals.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Cannabics Pharmaceuticals and Innovative Industrial Properties, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Cannabics Pharmaceuticals | 0 | 0 | 0 | 0 | N/A |
Innovative Industrial Properties | 0 | 2 | 5 | 0 | 2.71 |
Innovative Industrial Properties has a consensus target price of $192.4286, indicating a potential upside of 1.82%. Given Innovative Industrial Properties' higher probable upside, analysts clearly believe Innovative Industrial Properties is more favorable than Cannabics Pharmaceuticals.
Institutional & Insider Ownership
74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares Cannabics Pharmaceuticals and Innovative Industrial Properties' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Cannabics Pharmaceuticals | N/A | N/A | N/A |
Innovative Industrial Properties | 55.71% | 6.05% | 4.82% |
Summary
Innovative Industrial Properties beats Cannabics Pharmaceuticals on 8 of the 8 factors compared between the two stocks.